Skip to content
Home
News
About Us
Mission & Vision
Message from the CEO
Company Profile
Members
Access
Science & Technology
What Are Diabetes Stem Cells?
Complete Remission of Diabetes.
What Is Biozipcode™?
Cell-Targeting Technology
Academic Collaboration Overview
Dep. of Biocommunication Development (Kyoto Univ)
Domestic & Inter. Research Collaborations
Pipeline Overview
Diabetes Remission Therapy Candidate
Diabetes Stem Cell Biomarker
Biozipcode™ Cell-Targeted Diabetes Therapy
Cell-Targeted Oncology Therapeutics
Cell-Targeted Tissue Regeneration
Research Achievements
Selected Publications
Patents & Intellectual Property
Videos, Lectures & Presentations
For Partners
For Pharmaceutical Com. & Research Instit.
Research Collaboration
Technology Licensing
Co-development
Investment & Strategic Partnerships
Downloads
Contact
Contact Form
Legal & Policies
Privacy Policy
Website Policy
Cookie Policy
Medical & Scientific Disclaimer
Conflict of Interest & Transparency Policy
Japanese
Japanese
All News
All News
All News
biozipadmin
2026-09-26T13:21:39+09:00
Research & Development
Study on a Novel Candidate Cellular Biomarker for Type 2 Diabetes Published in Practical Laboratory Medicine
Study on a Novel Candidate Cellular Biomarker for Type 2 Diabetes Published in Practical Laboratory Medicine
2026-09-24
News
2026-04-01
Announcement of the Relocation of the Department of Biocommunication Development to Kyoto University and the Launch of Joint Industry–Academia Research
Read Article
News
2024-04-01
Visit to Ambassador Hiroyuki Orikasa at the Embassy of Japan in Palau
Read Article
News
2023-07-01
The Background to the Establishment of Biozipcode, Inc.
Read Article
Research & Development
2023-06-13
Research Suggesting the Possibility of a Cure for Diabetes Published in Communications Biology
Read Article
News
2022-09-20
Announcement of a Business Partnership with Co-LABO MAKER, a Tohoku University Startup
Read Article
News
2022-09-12
Biozipcode, Inc. to Exhibit at BioJapan2022
Read Article
1
2
Next
Page load link
Go to Top